Merck & Co., Inc. (6MK)
XDUS
Real-time Data
06:00 AM
Day's Range
125.6452 wk Range
71.10Overview - 6MK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
34.77B
P/E (Trailing)
‪17.57‬
EV / EBITDA
‪1.19‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪74.80%‬
Operating Margin
‪34.49%‬
Return on Assets
‪13.33%‬
Return on Equity
‪34.66%‬
Ownership
Shares Outstanding
2.46B
Price stats
50-Day Avg
‪89.95‬
200-Day Avg
‪76.25‬
Dividends
Frequency
Quarterly
Peers - 6MK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- 6MKXDUSMerck & Co., Inc.+48.63%52-week change17.58P/E (Trailing)‪74.80%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+46.37%52-week change-13.48P/E (Trailing)‪58.75%‬Profit Margin
- IDPXDUSBiogen Inc.+41.07%52-week change22.50P/E (Trailing)‪75.69%‬Profit Margin
- BAYNXDUSBayer AG+36.72%52-week change-12.16P/E (Trailing)‪58.75%‬Profit Margin
- JNJXDUSJohnson & Johnson+34.83%52-week change21.25P/E (Trailing)‪67.87%‬Profit Margin
- JNJ0XDUSJohnson & Johnson CDR+32.21%52-week change19.22P/E (Trailing)‪67.87%‬Profit Margin
- BRMXDUSBristol-Myers Squibb Company+31.19%52-week change16.07P/E (Trailing)‪71.08%‬Profit Margin
Profile Summary - 6MK - Merck & Co., Inc.
About
Merck & Co., Inc. is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, biologic therapies, and animal health products. The company’s pharmaceutical business serves areas such as oncology, immunology, infectious diseases, cardiometabolic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
